Dr. Valerie Bertaina-Anglade
Biotrial is a full-service CRO, established 30 years ago and has a broad experience in conducting non-Clinical and Clinical Studies from Phase I through to Phase IV for a global client base of pharmaceutical and biotech companies. Its services range from non-clinical pharmacology through to clinical trial management, from submission to Competent Authorities, Clinical conduct, Project Management, monitoring, Data Management, PK and Biostatistics to Medical Writing, coupled with allied services including Core Lab Services, Bio-analytical services and Clinical Trial Management (Oncology and phase II/IV Trial management). From its founding, Biotrial has been highly involved in CNS drug evaluation in man and in animals and has conducted many different clinical trials involving full assessments of psychoactive properties of compounds. Based in France, UK, Canada and US, with 350 employees and 260 beds, Biotrial performs hundreds of studies each year and offers tailor-made solutions for the pharmaceutical and biotech industries. In the PRIME consortium, its main task within WP1 will be to recruit a Romano-Ward patient cohort and matched healthy subjects in France and to conduct their clinical evaluation according to requirements defined by the WP1.
Biotrial declares no conflict of interest in PRIME.